GHUCCTS

News

Share This
  • Oct 22, 2020

TIN convalescent plasma study by former GHUCCTS KL2 scholar Dr. Seble Kassaye featured on NBC4

Dr. Seble Kassaye, infectious disease expert at Georgetown University Medical Center and former GHUCCTS KL2 scholar, is the principal investigator for a local convalescent plasma COVID-19 clinical trial. Dr. Kassaye recently appeared on NBC4 Washington to discuss the trial.

This trial is led by Johns Hopkins University. MedStar Georgetown University HospitalMedStar Washington Hospital Center, and Georgetown University Medical Center are serving as subsites for the trial, with support from GHUCCTS and the Trial Innovation Network (TIN). This study is for people at high risk of exposure to COVID-19, such as hospital personnel (clinical staff, environmental services, dining services, etc) or anyone who is caring for someone with COVID-19. This study will test whether an infusion of plasma containing antibodies from persons who have recovered from COVID-19 can prevent others from getting it.

Please visit www.covidplasmatrial.org/ or call 888-506-1199 for more information. 

Promotional flyer for Dr. Kassaye's COVID-19 plasma trial. Visit covidplasmatrial.org for more details.

Related News

TBS Grant Writing Workshop (GWW) Series registration is now open for the 2021-2022 cycle.

Sep 08, 2021

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Translational Biomedical Science (TBS) Program is offering a 6 month Grant Writing Workshop Series

GHUCCTS announces 2021 KL2 Scholars Dr. Maurice Fluitt & Dr. Roxanne Mirabal-Beltran

Aug 10, 2021

After our 11th highly competitive application cycle, unfortunately delayed due to COVID-related research closures, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Dr. Maurice Fluitt and Dr. Roxanne Mirabal-Beltran as a KL2 Scholar.

GHUCCTS featured in National Black Nurses Association for Howard University's Novavax COVID-19 Clinical Trial

May 28, 2021

GHUCCTS is featured in the Winter 2021 edition of the National Black Nurses Association (NBNA) Newsletter for our work helping with the planning, recruitment, and implementation efforts of the Novavax COVID-19 vaccine study at Howard University.

Close